Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides.

MLA

Berezina, Tetiana A., et al. “Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides.” Diagnostics (2075-4418), vol. 14, no. 16, Aug. 2024, p. 1728. EBSCOhost, https://doi.org/10.3390/diagnostics14161728.

APA

Berezina, T. A., Berezin, O. O., Hoppe, U. C., Lichtenauer, M., & Berezin, A. E. (2024). Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides. Diagnostics (2075-4418), 14(16), 1728. https://doi.org/10.3390/diagnostics14161728

Chicago

Berezina, Tetiana A., Oleksandr O. Berezin, Uta C. Hoppe, Michael Lichtenauer, and Alexander E. Berezin. 2024. “Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides.” Diagnostics (2075-4418) 14 (16): 1728. doi:10.3390/diagnostics14161728.